BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6698110)

  • 1. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT; Lefer AM
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT; Lefer AM
    Eur J Pharmacol; 1982 Mar; 78(3):307-13. PubMed ID: 6279411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE; Curtis MT; Jaffe JS; Lefer AM
    Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Am J Physiol; 1979 Feb; 236(2):H280-5. PubMed ID: 311160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL; Bitterman H; Terashita Z; Lefer AM
    Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT; Lefer AM
    Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H; Triolo J; Lefer AM
    Circ Shock; 1987; 21(4):271-83. PubMed ID: 3581442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG; Hock CE; Edmonds JS; Lefer AM
    J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer DJ; Lefer AM
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril and the intestinal response to hemorrhagic shock.
    Rosenfeld LM; Cooper HS
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):144-52. PubMed ID: 6758718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs.
    Knight DR; Kirby DA; Vatner SF
    Hypertension; 1985; 7(3 Pt 1):380-5. PubMed ID: 3158603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.